Diabetes Research and Clinical Practice
Volume 88, Issue 2 , Pages 189-195 , May 2010

Predictors of diastolic dysfunction among minority patients with newly diagnosed type 2 diabetes

  • Rasa Kazlauskaite

      Affiliations

    • Division of Endocrinology, John H Stroger Jr Hospital of Cook County and Rush University Medical Center, Chicago, IL,United States
    • Corresponding Author InformationCorresponding author at: Rush University Medical Center, Department of Preventive Medicine, 1700 W. Van Buren St., Room 470, Chicago, IL 60612, United States. Tel.: +1 312 942 3133; fax: +1 312 563 2477.
    • ,
  • Rami Doukky

      Affiliations

    • Division of Cardiology, John H Stroger Jr Hospital of Cook County and Rush University Medical Center, Chicago, IL,United States
    • ,
  • Arthur Evans

      Affiliations

    • Collaborative Research Unit, John H Stroger Jr Hospital of Cook County and Rush University Medical Center, Chicago, IL, United States
    • ,
  • Bosko Margeta

      Affiliations

    • Division of Cardiology, John H Stroger Jr Hospital of Cook County and Rush University Medical Center, Chicago, IL,United States
    • ,
  • Arora Ruchi

      Affiliations

    • Department of Family Medicine, University of Illinois, Chicago, IL, United States
    • ,
  • Leon Fogelfeld

      Affiliations

    • Division of Endocrinology, John H Stroger Jr Hospital of Cook County and Rush University Medical Center, Chicago, IL,United States
    • ,
  • Russell F. Kelly

      Affiliations

    • Division of Cardiology, John H Stroger Jr Hospital of Cook County and Rush University Medical Center, Chicago, IL,United States

Received 14 June 2009 ,Revised 1 December 2009 ,Accepted 7 December 2009.

References 

  1. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154–e235
  2. Galderisi M, Anderson KM, Wilson PW, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol. 1991;68(1):85–89
  3. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care. 2004;27(8):1879–1884
  4. Bell DS. Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care. 2003;26(8):2433–2441
  5. Ammar KA, Jacobsen SJ, Mahoney DW, Kors JA, Redfield MM, Burnett JC, et al. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation. 2007;115(12):1563–1570
  6. Achong N, Wahi S, Marwick TH. Evolution and outcome of diastolic dysfunction. Heart. 2009;95(10):813–818
  7. Kuznetsova T, Herbots L, Lopez B, Jin Y, Richart T, Thijs L, et al. Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail. 2009;2(2):105–112
  8. Smart N, Haluska B, Jeffriess L, Marwick TH. Exercise training in systolic and diastolic dysfunction: effects on cardiac function, functional capacity, and quality of life. Am Heart J. 2007;153(4):530–536
  9. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26(11):3160–3167
  10. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645
  11. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation. 1981;64(6):1227–1234
  12. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527–1539
  13. Bush B, Shaw S, Cleary P, Delbanco TL, Aronson MD. Screening for alcohol abuse using the CAGE questionnaire. Am J Med. 1987;82(2):231–235
  14. National Health and Nutrition Examination Survey Physician's Examination Procedures Manual. 1999/2000;Available from: http://www.cdc.gov/nchs/data/nhanes/pe.pdf [cited May 1, 2004]
  15. Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation. 1987;75(3):565–572
  16. Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289(2):194–202
  17. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992;20(5):1251–1260
  18. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res. 2003;11(2):304–310
  19. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation. 2004;109(25):3176–3181
  20. Hammer S, Snel M, Lamb HJ, Jazet IM, van der Meer RW, Pijl H, et al. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol. 2008;52(12):1006–1012
  21. van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation. 2008;117(1):43–51
  22. Jarnert C, Landstedt-Hallin L, Malmberg K, Melcher A, Ohrvik J, Persson H, et al. A randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: a report from the DADD (diabetes mellitus and diastolic dysfunction) study. Eur J Heart Fail. 2009;11(1):39–47
  23. Loimaala A, Groundstroem K, Rinne M, Nenonen A, Huhtala H, Vuori I. Exercise training does not improve myocardial diastolic tissue velocities in Type 2 diabetes. Cardiovasc Ultrasound. 2007;5:32
  24. Okura H, Takada Y, Yamabe A, Kubo T, Asawa K, Ozaki T, et al. Age- and gender-specific changes in the left ventricular relaxation: a doppler echocardiographic study in healthy individuals. Circ Cardiovasc Imaging. 2009;2(1):41–46
  25. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005;2(10):536–543
  26. Kankaanpaa M, Lehto HR, Parkka JP, Komu M, Viljanen A, Ferrannini E, et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab. 2006;91(11):4689–4695

PII: S0168-8227(09)00532-4

doi: 10.1016/j.diabres.2009.12.007

Diabetes Research and Clinical Practice
Volume 88, Issue 2 , Pages 189-195 , May 2010

Article Tools